CHICAGO -- Men with metastatic castration-sensitive prostate cancer (mCSPC) and DNA repair alterations had significantly longer progression-free survival (PFS) with a targeted drug plus an androgen receptor pathway inhibitor (ARPI),...

Experts at the Primary Care Show identified the key barriers to lipid management — and what clinicians can do about them. Medscape News UK Source link : https://www.medscape.com/viewarticle/tackling-barriers-lipid-management-primary-care-2026a1000i26?src=rss Author :...

In the first phase 3 trial of a RET inhibitor as adjuvant therapy, selpercatinib markedly improved event-free survival vs placebo in early-stage RET fusion-positive NSCLC. Medscape Medical News Source link...

CHICAGO -- RASolute 302 trial results were hailed as a game-changing breakthrough in the treatment of pancreatic cancer. The phase III study showed that second-line daraxonrasib, an investigational oral RAS(ON)...

Rochelle Lewis is among more than 170 million woman globally to be diagnosed with PCOS. Source link : https://www.bbc.com/news/articles/cd9p50j3ljko?at_medium=RSS&at_campaign=rss Author : Publish date : 2026-05-31 06:13:00 Copyright for syndicated content...

CHICAGO -- Adding an investigational TROP2-targeted antibody-drug conjugate (ADC) to first-line immunotherapy for PD-L1-positive non-small cell lung cancer (NSCLC) reduced the risk of disease progression and may have improved survival...

When an oncologist learns one patient’s story, everything shifts, including his approach to consultations. Medscape Medical News Source link : https://www.medscape.com/viewarticle/doctor-helps-woman-stop-blaming-herself-and-accept-treatment-2026a1000i20?src=rss Author : Publish date : 2026-05-30 20:22:00 Copyright for...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech...

Patients in full remission from endometrial cancer who underwent fertility-preserving treatment before cancer treatment had less IVF success than matched controls.The question remains as to what exactly drives this difference...

I have spent 20 years working in out-of-network healthcare reimbursement. After reading the New York Times article "A $440,000 Breast Reduction? How Doctors Cash In on a Health Care Law,"...

CHICAGO -- Combining two targeted therapies with standard-of-care chemotherapy extended progression-free survival (PFS) in patients with newly diagnosed B-cell lymphomas, according to data from the frontMIND trial. In the phase...

President Donald Trump on Friday gave his endorsement to a January study by HHS that calls for cutting the number of vaccines recommended for every American child. An executive order...

Editor's Note: This story includes discussion of suicide. If you or someone you know needs help, the national suicide and crisis lifeline in the U.S. is available by calling or...

The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection....

Tafasitamab and lenalidomide are likely to be approved with R-CHOP for frontline DLBCL, but with bispecific antibodies on the horizon, the role of the combination is uncertain. Medscape Medical News...

The GammaTile may improve outcomes over standard stereotactic RT after resection of large brain metastases, but a striking overall survival benefit in a phase 3 trial raises questions. Medscape Medical...

CHICAGO -- Radioactive tiles implanted immediately after the surgical resection of a newly diagnosed brain metastasis improved local control over standard stereotactic radiotherapy (SRT) given weeks later, findings of a...

CHICAGO -- Adding a multicancer early detection (MCED) blood test to standard of care did not reduce the number of cancers detected at stage III or IV across a dozen...

CHICAGO -- Skipping axillary lymph node dissection (ALND) for selected patients with locally advanced breast cancer did not adversely affect survival, findings from a randomized trial showed. Patients who omitted...

A father mysteriously slips through time in Joseph Eckert’s The TravelerMikhail Rudenko / Alamy Writing this as the UK swelters under an unprecedented May heatwave, perhaps it’s small wonder that...